Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by MrMugsyon Oct 09, 2021 11:01am
351 Views
Post# 33991838

RE:RE:RE:RE:AME

RE:RE:RE:RE:AME I have never seen a stock that wen't to half cash value but then again ... I've never paid this much attention to a drug development company before.

I couldn't imagine it getting to 50 cents or even 75 cents but I certainly would evaluate the situation at that time - if the price dropped.

I have been buying back on the daily now - so if it drops on no news - guess logic would dictate that I would keep buying.  Slow and steady IMO !!!

: )





Inthepez wrote: Same here. But I’ll be buying anything under $1.

all these fud fairies wouldn’t be commenting on this stock if they didn’t have a stake in it. Bunch of b!tches that love to complain and spread false info. 

Im looking at you: ratbar, yukonjizza, the xdresser, and of course dusty. Although dusty has been MIA lately lmao! 

TheMadMonk wrote: I don't know about Mugsy, but if this thing drops to 50 cents, I will buy everything I can get my hands on.  The funny thing is that no one here expects it to drop below a dollar because if you did expect it to drop, you would sell now.   




<< Previous
Bullboard Posts
Next >>